Legal & General Group
VERA icon

Legal & General Group’s Vera Therapeutics VERA Stock Holding History

Legal & General Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
34,998
+1,040
+3% +$38.8K ﹤0.01% 2056
2026
Q1 		$1.37M Sell
33,958
-12,468
-27% -$537K ﹤0.01% 2045
2025
Q4 		$2.35M Sell
46,426
-4,837
-9% -$172K ﹤0.01% 1905
2025
Q3 		$1.49M Buy
51,263
+845
+2% +$19.5K ﹤0.01% 2102
2025
Q2 		$1.19M Buy
50,418
+825
+2% +$18.6K ﹤0.01% 2181
2025
Q1 		$1.19M Buy
49,593
+1,784
+4% +$57.3K ﹤0.01% 2120
2024
Q4 		$2.02M Buy
47,809
+8,313
+21% +$368K ﹤0.01% 1978
2024
Q3 		$1.75M Buy
39,496
+123
+0.3% +$4.67K ﹤0.01% 2037
2024
Q2 		$1.42M Buy
39,373
+1,661
+4% +$65.9K ﹤0.01% 2075
2024
Q1 		$1.63M Buy
37,712
+12,722
+51% +$453K ﹤0.01% 2018
2023
Q4 		$384K Hold
24,990
– – ﹤0.01% 2553
2023
Q3 		$343K Buy
24,990
+21,373
+591% +$367K ﹤0.01% 2583
2023
Q2 		$58.1K Buy
3,617
+1,038
+40% +$9.38K ﹤0.01% 2861
2023
Q1 		$20K Sell
2,579
-3,327
-56% -$25.7K ﹤0.01% 3065
2022
Q4 		$114K Buy
5,906
+520
+10% +$9.42K ﹤0.01% 2789
2022
Q3 		$114K Buy
5,386
+488
+10% +$9.14K ﹤0.01% 2778
2022
Q2 		$67K Buy
4,898
+3,591
+275% +$62.7K ﹤0.01% 2947
2022
Q1 		$31K Buy
1,307
+374
+40% +$8.05K ﹤0.01% 3120
2021
Q4 		$25K Buy
933
+271
+41% +$5.99K ﹤0.01% 3204
2021
Q3 		$12K Buy
+662
New +$11.8K ﹤0.01% 3421

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Legal & General Group's VERA Position: Q2 2026 in Review

Legal & General Group increased its Vera Therapeutics (VERA) stake by 3.1% in Q2 2026, buying an estimated $38.8K and bringing the position to 34,998 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

Legal & General Group first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.35M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Legal & General Group held 34,998 shares of Vera Therapeutics worth $1.5M as of Q2 2026.
  • Legal & General Group bought 1,040 Vera Therapeutics shares in Q2 2026, an estimated $38.8K.
  • Vera Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2056 holding.
  • Legal & General Group first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Legal & General Group's Vera Therapeutics position peaked at $2.35M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.